Condensed Parent Only Financial Information - Condensed Statements of Cash Flows (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (1,699,811)	$ (935,240)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:
Total adjustments	(523,915)	(545,580)
Net cash flows used in operating activities	(2,223,726)	(1,480,820)
Cash flows from investing activities:
Net cash flows provided by (used in) investing activities	(9,574,838)	9,456,065
Cash flows from financing activities:
Proceeds from issuance of common stock, net of costs	5,478,242	0
Loan to ESOP	526,780	0
Net cash flows provided by (used in) financing activities	11,378,489	(9,508,939)
Net change in cash and cash equivalents	(420,075)	(1,533,694)
Cash and cash equivalents at beginning of period	1,608,709	3,142,403
Cash and cash equivalents at end of period	1,188,634	1,608,709
Parent | Reportable legal entities
Cash flows from operating activities:
Net income (loss)	(1,699,811)	(935,240)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:
Net decrease (increase) in other assets and liabilities	67,195
Equity in undistributed net income (loss) of subsidiary	1,657,051	935,240
Total adjustments	1,724,246	935,240
Net cash flows used in operating activities	24,435
Cash flows from investing activities:
Principal payments on loan to ESOP	39,028
Net cash flows provided by (used in) investing activities	39,028
Cash flows from financing activities:
Proceeds from issuance of common stock, net of costs	5,478,242
Loan to ESOP	(526,780)
Proceeds from conversion transferred to subsidiary	(4,918,928)
Cash transferred from prior holding company	210,463
Net cash flows provided by (used in) financing activities	242,997
Net change in cash and cash equivalents	306,460
Cash and cash equivalents at beginning of period	50,000	50,000
Cash and cash equivalents at end of period	$ 356,460	$ 50,000